Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Celgene Corp (NASDAQ: CELG)

Last Updated: Dec-07-2016 08:25:35

Premium Research

Celgene Corp (NASDAQ: CELG) Profile

Prior Close$117.39
Market Cap$89.6 B
PE Ratio24.03
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery development and commercialization of orally administered small molecule drugs for the treatment of cancer and immunological diseases.
SymbolCompanyMarket cap
GILDGilead Sciences Inc$95.33 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$28.02 B
ALIOFActelion Ltd$22.5 B
INCYIncyte Corporation$19.74 B
ILMNIllumina Inc$18.79 B
VRTXVertex Pharmaceutic$18.74 B
BMRNBiomarin Pharmaceut$14.18 B
SGENSeattle Genetics Inc$9.38 B
ALKSAlkermes Plc$8.54 B

CELG Earnings

1st Quarter Earnings$1.58 (2016-10-27)
2nd Quarter Earnings$1.44 (2016-07-28)
3rd Quarter Earnings$1.32 (2016-04-28)
4th Quarter Earnings$1.18 (2016-01-28)
PE Ratio24.03
EPS Growth29.03%
Recent Earnings$1.58
Annual EPS$4.85
Market Capitalization$89.6 B
Insider Shareholder %0.0097%
Annual Revenue$10.81 B
Number of Shares Outstanding775,120 Shares
Institutional Shareholder %76.43%
Annual Net Income$2.13B
TTM Net Profit Margin$19.71
One Year Return4.77%
Three Year Return28.9%
Five Year Return269.27%
Five Year Revenue Growth155.29%
Five Year Earnings Growth234.43%
Five Year Dividend Growth0%
Last Quarter EPS$1.39
Annual EPS$4.85
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD29.030001%
PE Ratio24.03
Recent Earnings$1.58
Dividends per Share$
Stock Split Ratio2-1

CELG Key Stats

Last Price$115.6
Net Change$-1.79 (-1.52%)
Ask Price$115.9
Open Price$115.6
Previous Close Price$117.39
High Price$115.6
Low Price$115.6
Number of Trades22
Fifty Two Week High$127 (2016-11-09)
Fifty Two Week Low$93.05 (2016-02-03)
Average Daily Volume5,000,625
Share Outstanding775,120 Shares
Total Dividend Payout$0/yr
Dividend Yield0%